The THINK HADRON 2025 meeting aims to explore the state of the art in the diagnosis and treatment of these rare malignancies, with a focus on the integration of advanced imaging, molecular profiling, and emerging treatment modalities, including hadrontherapy. In this context, the role of collaborative networks, national and international, becomes fundamental to ensure adequate patient management, data sharing, and access to highly specialized treatments.